TheNote.app
Science Magazine | AAAS: Science Translational Medicine

Kras G12C– and G12D–driven lung cancers differ in oncogenic potency, immunogenicity, and relapse after Kras inhibition in mouse models | Science Translational Medicine

KRAS G12D and G12C produce lung tumors with distinct microenvironmental and growth features that influence progression and survival.
favicon
science.org
science.org
Image for the article: Kras G12C– and G12D–driven lung cancers differ in oncogenic potency, immunogenicity, and relapse after Kras inhibition in mouse models | Science Translational Medicine
RSS Hunter
Create attached notes ...